Vasodilation by hyperpolarization: Beyond NO

Hypertension

Volumn 48, Issue 6, 2006, Pages 1023-1025

  Quyyumi, Arshed A ^a,b   Ozkor, Muhiddin ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APAMIN; ARACHIDONIC ACID; BRADYKININ; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; FLUCONAZOLE; HYDROGEN PEROXIDE; LIPOXYGENASE; MICONAZOLE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TETRYLAMMONIUM CHLORIDE; XANTHINE OXIDASE;

ARTERY BLOOD FLOW; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; EDITORIAL; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; EPOXIDATION; HUMAN; HYPERPOLARIZATION; ION TRANSPORT; MICROCIRCULATION; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SHEAR STRESS; TOXICITY; VASODILATATION;

BIOLOGICAL FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; PROSTAGLANDINS; VASODILATION;

EID: 33751089585     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000250965.03934.15     Document Type: Editorial

References (19)

1. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995;92:320-326.
2. Gilligan DM PJ, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation. 1994;90:2853-2858.
3. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
4. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, Deanfield JE, MacAllister RJ. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res. 2001;88:145-151.
5. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26:1215-1225.
6. Fleming I, Busse R. Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension. 2006;47:629-633.
7. Miura H, Wachtel RE, Liu Y, Loberiza FR, Jr., Saito T, Miura M, Gutterman DD. Flow-induced dilation of human coronary arterioles: important role of Ca2+-activated K+ channels. Circulation. 2001;103:1992-1998.
8. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun. 2002;290:909-913.
9. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44-51.
10. Christ GJ, Spray DC, El-Sabban M, Moore LK, Brink PR. Gap junctions in vascular tissues: evaluating the role of intercellular communication in the modulation of vasomotor tone. Circ Res. 1996;79:631-646.
11. Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, Quyyumi AA. Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol Heart Circ Physiol. 2001;280:H2470-H2477.
12. Bellien J, Joannides R, Iacob M, Arnaud P, Thuillez C. Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans. Am J Physiol Heart Circ Physiol. 2006;290:H1347-H1352.
13. Bellien JM, Iacob M, Gutierrez L, Isabelle M, Lahary A, Thuillez C, Joannides R. Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation. Hypertension 2006;48:1088-1094.
14. Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, Fleming I. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation. 2004;109:178-183.
15. Honing MLH, Smits P, Morrison PJ, Rabelink TJ. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension. 2000;35:1314-1318.
16. Dawes M, Sieniawska C, Delves T, Dwivedi R, Chowienczyk PJ, Ritter JM. Barium reduces resting blood flow and inhibits potassium-induced vasodilation in the human forearm. Circulation. 2002;105:1323-1328.
17. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation. 1999;100:1400-1405.
18. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res. 2003;92:e31e-e40.
19. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.[comment]. N Engl J Med. 2003;348:593-600.